ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,016,000 | -96.8% | 1,000,000 | -96.4% | 0.01% | -98.7% |
| Q3 2019 | $31,890,000 | -10.0% | 27,901,000 | -6.7% | 0.88% | -11.8% |
| Q2 2019 | $35,434,000 | +14.8% | 29,901,000 | +31.2% | 1.00% | -17.1% |
| Q1 2019 | $30,872,000 | +194.6% | 22,795,000 | +133.8% | 1.20% | +60.0% |
| Q4 2018 | $10,480,000 | +19.3% | 9,748,000 | +16.8% | 0.75% | +139.5% |
| Q3 2018 | $8,786,000 | +6.9% | 8,348,000 | 0.0% | 0.31% | -37.5% |
| Q2 2018 | $8,222,000 | -17.3% | 8,348,000 | -16.7% | 0.50% | -32.1% |
| Q1 2018 | $9,942,000 | +14.6% | 10,025,000 | +22.3% | 0.74% | -7.9% |
| Q4 2017 | $8,677,000 | -19.6% | 8,200,000 | -19.6% | 0.80% | -7.8% |
| Q3 2017 | $10,799,000 | +84.7% | 10,200,000 | +85.5% | 0.87% | +53.2% |
| Q2 2017 | $5,847,000 | +92.8% | 5,500,000 | +83.3% | 0.57% | +117.6% |
| Q4 2016 | $3,032,000 | +62.5% | 3,000,000 | +50.0% | 0.26% | +30.5% |
| Q3 2016 | $1,866,000 | -62.4% | 2,000,000 | -71.4% | 0.20% | -68.5% |
| Q2 2016 | $4,966,000 | -32.0% | 7,000,000 | -12.5% | 0.63% | -46.3% |
| Q1 2016 | $7,300,000 | -28.1% | 8,000,000 | -11.1% | 1.18% | -39.0% |
| Q4 2015 | $10,148,000 | – | 9,000,000 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|